Physician profile
Mark A Hebert
NPI 1831740331
$701.38
in general payments reported to CMS, 2019-2025
7 companies · $571 in 2025
The $571 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $40.41 · 2024: $90.00 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422 · Education: $149 · Consulting Fee: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.11 |
| Education | $148.86 |
| Consulting Fee | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $223.62 | 2025 | Carvykti, Rybrevant, Erleada |
| Genzyme Corporation | $147.85 | 2025 | |
| Astellas Pharma US INC | $121.13 | 2025 | Padcev |
| Janssen Scientific Affairs, LLC | $119.50 | 2024-2025 | Talvey, Darzalex, Carvykti |
| Astrazeneca Pharmaceuticals Lp | $48.87 | 2025 | |
| Abbvie INC. | $24.82 | 2022 | |
| Pfizer INC. | $15.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.